Venturepharm Rides Chinese Wave Of CRO Growth; Sees Challenges Ahead As Competition Among MNCs, Locals Increase
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The growth of contract research organizations in China has been little short of astounding. China has overtaken India as one of the fastest-growing locations for drug trials, leveraging a huge population and Western-trained doctors into a competitive industry